All Videos Channels
  1. BREAKING NEWS: DARPA Unclassified documents confirm SARS-CoV-2 was created by EcoHealth Alliance

    BREAKING NEWS: DARPA Unclassified documents confirm SARS-CoV-2 was created by EcoHealth Alliance

    4
    0
    86
  2. Chicken Egg Yolk Antibodies (IgYs) block binding of multiple SARS-CoV-2 spike protein

    Chicken Egg Yolk Antibodies (IgYs) block binding of multiple SARS-CoV-2 spike protein

    4
    0
    163
    1
  3. Dr. Wu Zunyou from CID admits on NBC that THEY DIDN'T ISOLATE THE SARS-COV-2

    Dr. Wu Zunyou from CID admits on NBC that THEY DIDN'T ISOLATE THE SARS-COV-2

    3
    0
    69
  4. Para ter uma ideia do tamanho do vírus SARS-CoV-2 que consegue ser milagrosamente parado pelas máscaras de fantasia que querem fazer vc voltar a usar.

    Para ter uma ideia do tamanho do vírus SARS-CoV-2 que consegue ser milagrosamente parado pelas máscaras de fantasia que querem fazer vc voltar a usar.

    4
    0
    31
  6. Dr. Richard Urso: "Tenemos pacientes con SARS-Cov-1 que aún tenían inmunidad"

    Dr. Richard Urso: "Tenemos pacientes con SARS-Cov-1 que aún tenían inmunidad"

    4
    0
    161
  7. “It was all known in 2015 that SARS-COV-2 was an engineered product by U.S.

    “It was all known in 2015 that SARS-COV-2 was an engineered product by U.S.

    5
    0
    24
  8. DARPA Unclassified documents confirm SARS-CoV-2 was created by EcoHealth Alliance

    DARPA Unclassified documents confirm SARS-CoV-2 was created by EcoHealth Alliance

    3
    0
    131
  9. “新冠實驗針劑災難實證醫學追蹤”根據2022年超額死亡人數日本科學家得出結論，在接種三劑 SARS-CoV-2 mRNA疫苗後，死於六種對“雌激素受體-α 敏感的特定類型癌症”，導致死亡的人數顯著增加

    “新冠實驗針劑災難實證醫學追蹤”根據2022年超額死亡人數日本科學家得出結論，在接種三劑 SARS-CoV-2 mRNA疫苗後，死於六種對“雌激素受體-α 敏感的特定類型癌症”，導致死亡的人數顯著增加

    90
  10. REMINDER: Peter Daszak described the exact process of creating a virus like SARS-CoV-2 at the Wuhan Lab on March 28, 2016.

    REMINDER: Peter Daszak described the exact process of creating a virus like SARS-CoV-2 at the Wuhan Lab on March 28, 2016.

    52
    1
    14.3K
    5
  12. BREAKING NEWS: DARPA UNCLASSIFIED DOCUMENTS CONFIRM SARS-COV-2 WAS CREATED BY ECOHEALTH ALLIANCE

    BREAKING NEWS: DARPA UNCLASSIFIED DOCUMENTS CONFIRM SARS-COV-2 WAS CREATED BY ECOHEALTH ALLIANCE

    54
    1
    2.3K
  13. Ivermectina para el covid-19 - Sars Cov 2

    Ivermectina para el covid-19 - Sars Cov 2

    323
  14. Fauci Boasts That His Group Developed the SARS-COV-2 mRNA Vaccine for Moderna

    Fauci Boasts That His Group Developed the SARS-COV-2 mRNA Vaccine for Moderna

    3
    0
    54
  15. SARS-CoV-2「ウイルス」の存在証明はない 世界30か国、156研究機関

    SARS-CoV-2「ウイルス」の存在証明はない 世界30か国、156研究機関

    28
  16. Nattokinase degrades the nasty Spike protein in SARS-CoV-2

    Nattokinase degrades the nasty Spike protein in SARS-CoV-2

    3
    0
    147
  17. SARS CoV-2 S1 Protein in CD16+ Monocytes in Post-Acute Sequelae of COVID-19 (PASC)

    SARS CoV-2 S1 Protein in CD16+ Monocytes in Post-Acute Sequelae of COVID-19 (PASC)

    9
    0
    29
  18. Dr. Redfield, former CDC Director, believes that NIH, USAID, DOD funded creation of SARS-CoV-2

    Dr. Redfield, former CDC Director, believes that NIH, USAID, DOD funded creation of SARS-CoV-2

    2
    0
    93
  19. Dr. Robert Redfield - NIH, USAID and DOD funded the creation of SARS-CoV-2

    Dr. Robert Redfield - NIH, USAID and DOD funded the creation of SARS-CoV-2

    6
    0
    116
  20. Dr. David Martin Details the Eye-Opening Patent for a 'Weapon' That Preceded SARS-CoV-1

    Dr. David Martin Details the Eye-Opening Patent for a 'Weapon' That Preceded SARS-CoV-1

    2
    0
    93
  23. LE MINISTÈRE DE LA SANTÉ, QUI POURTANT IMPOSE L'INJECTION NE SAIT PAS QUELLE EST SA COMPOSITION !!!

    LE MINISTÈRE DE LA SANTÉ, QUI POURTANT IMPOSE L'INJECTION NE SAIT PAS QUELLE EST SA COMPOSITION !!!

    18
    0
    1.14K
  24. Vietnam-style SARS-CoV-2 prevention

    Vietnam-style SARS-CoV-2 prevention

    4
    0
    39
  25. Are SARS-CoV-2 variants really dangerous? Michael Yeadon | COMMENTARY #22

    Are SARS-CoV-2 variants really dangerous? Michael Yeadon | COMMENTARY #22

    2
    0
    33